Regeneron Pharmaceuticals, Inc. ( REGN) - Key Metrics

REGN Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $37.75 $8.21 ? ?
2025Q3 $36.23 $14.09 $15.62 $13.68
2025Q2 $34.97 $13.24 $10.89 $9.21
2025Q1 $28.39 $7.58 $9.79 $7.25

REGN Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 10.72% 23.51
2025Q3 6.25% 9.98
2025Q2 6.65% 9.91
2025Q1 11.60% 20.92

REGN Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 1.06% ?
2025Q4 1.16% 0.11%
2025Q3 2.43% 0.16%
2025Q2 1.75% 0.17%
2025Q1 1.14% 0.14%

REGN

Price: $676.69

52 week price:
532.60
821.11

Dividend Yield: 0.56%

5-year range yield:
0.49%
0.63%

Forward Dividend Yield: 0.56%

Payout Ratio Range:
1.95%
425.53%

Dividend Per Share: 3.76 USD

Earnings Per Share: 40.99 USD

P/E Ratio: 17.13

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 417600

Ebitda: 597.4 million

Market Capitalization: 67.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 2

Links: